Form 4: MariMed Director Eva Selhub Exercises 75,000 RSUs

Director Eva Selhub acquired 75,000 shares of MariMed Inc. common stock through the vesting and conversion of restricted stock units.

Summary

• Director Eva Selhub exercised 75,000 Restricted Stock Units (RSUs) on June 12, 2026.
• The RSUs converted into 75,000 shares of common stock on a one-for-one basis.
• The transaction resulted in a total beneficial ownership of 557,671 shares of common stock held directly by the director.
• The RSUs were originally granted on June 12, 2025, and are now fully settled.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event representing the routine vesting of director compensation.

Positives

• Director maintains a significant equity stake of 557,671 shares, aligning interests with shareholders.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership in the cannabis sector.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that insider equity exercises are standard corporate governance practices, reflecting the vesting of long-term incentive compensation for board members in the cannabis industry.

Comparison to Industry Standards

• The conversion of RSUs is consistent with standard executive and director compensation packages in the U.S. cannabis sector.
• The holding level of 557,671 shares is typical for a non-executive director at a company of MariMed's market capitalization.

Stakeholder Impact

• Minimal impact on shareholders as this represents the fulfillment of existing compensation agreements.

Next Steps

• No further actions mentioned.

Key Dates

Keywords

MariMed, MRMD, Form 4, Insider Trading, Equity Compensation, Director Ownership